Hrubá marže společnosti Apellis Pharmaceuticals Inc

Jaká je hodnota metriky Hrubá marže společnosti Apellis Pharmaceuticals Inc?

Hodnota metriky Hrubá marže společnosti Apellis Pharmaceuticals Inc je 85.25%

Jaká je definice metriky Hrubá marže?



Hrubá marže (Gross margin) je rozdíl mezi příjmy a náklady na prodané zboží dělený příjmy a vyjádřený v procentech.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Hrubá marže společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Apellis Pharmaceuticals Inc

Čemu se věnuje společnost Apellis Pharmaceuticals Inc?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Firmy s metrikou hrubá marže podobnou společnosti Apellis Pharmaceuticals Inc